Search
ApexOnco's Jacob Plieth shares his take on what to watch for at the 2024 ASH Annual Meeting
He talks modalities and targets, and comments on Arcellx, Galapagos, BeiGene, Nurix, Kura, JNJ, Syndax, AbbVie AstraZeneca, CellCentric,...
Dec 7, 2024
ApexOnco's Jacob Plieth previews #ASCO24
From McCormick Place, Jacob Plieth previews key data from Merus, Summit, Iovance, Caribou, AstraZeneca, GSK, Gilead, and more.
May 31, 2024
Kicking off Monday (Day 3) of the ASH Annual Meeting with ApexOnco's Jacob Plieth
Jacob Plieth shares his thoughts on MorphoSys, Syndax, Poseida, Arcellx, Autolus, Cogent, Dizal, and more.
Dec 11, 2023
Previewing #ASCO23 with Jacob Plieth
Evaluate Vantage's Jacob Plieth previews what to watch for at the 2023 ASCO Annual Meeting in Chicago.
Jun 2, 2023
.png){kind=logo}
